Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Biota Pharmaceuticals, Inc. (NASDAQ:NABI.DL)

CAPS Rating: No stars

The Company leverage its experience and knowledge in powering the human immune system to develop and market products that target serious medical conditions in the areas of transplantation, infectious disease and hematology/oncology.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

1 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NABI.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.22)
Submitted September 28, 2012

This is a rather uninspiring play on a busted biopharma. After the phase III trials of NicVAX failed last year, just about everybody lost interest in Nabi. The company has substantial cash but zero pipeline and in April they agreed to a reverse… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:NABI.DL Summary

  • Sector:
  • Industry:
  • Tags:

Fools bullish on NASDAQ:NABI.DL are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about NABI.DL.

No one has written a Pitch for NABI.DL stock yet. Tell us why you think NABI.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in NABI.DL.

Score Leader

Reallynow222

Reallynow222 (85.34) Score: +520.58

The Score Leader is the player with the highest score across all their picks in NABI.DL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
veteranshipper < 20 9/2/2020 Outperform 5Y $10.80 0% +19.57% -19.57 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NABI.DL.